Niflad ES 600mg/42.9mg Imexpharm Treatment of skin infections, chronic purulent dermatitis (4 blisters x 7 tablets)

Dosage form 4 blister bags x 7 tablets
Specifications Clavulanic acid, amoxicilin

Ingredient

Thành phần cho 1 viên

Composition informationContent
Clavulanic acid42.9mg
Amoxicilin600mg

Uses

Indications

Niflad ES 600mg/42.9mg is used to treat cases of bacterial infections caused by sensitive bacteria such as:

  • Skin infection and subcutaneous organization, chronic pus dermatitis. Beta-lactamase.

    ATC code: J01CR02

    Amoxicilin is a semi -synthetic antibiotic in the penicillin group, which has a bactericidal effect due to the drug attached to one or more penicillin -mounted proteins of bacteria (PBPS) to inhibit peptidoglycan biosynthesis, an important component of bacterial cell walls. This inhibitor weakens the cell wall leading to bacteria decomposed and die.

    Amoxicillin is easily destroyed by beta-lactamase enzymes and therefore the antibacterial spectrum of the monoclonal amoxicillin does not include bacteria that produce these enzymes. Clavulanic acid is a beta-lactam, structurally related to penicillin. Clavulanic acid has the ability to inhibit beta-lactamase enzymes and thus prevent inactivity to amoxicillin.

    Clavulanic acid monomers do not have clinical antibacterial effects. Mobile pharmacokinetics/ pharmacokinetic association: The time of antibiotic concentration is higher than the minimum inhibitory concentration (T> MIC) is the main parameter that shows the effect of amoxicillin.

    Resistance mechanism:

    Two resistance mechanisms with amoxicillin combination and clavulanic acid:

  • Inactivated drugs by beta-lactamase not inhibited by clavulanic acid including beta-lactamase B, C, D. Part of the bacterial resistance, especially in Gram -negative bacteria.

    Antibacterial spectrum of drugs: often sensitive bacteria:

  • Aerobic Gram -positive bacteria: Staphylococcus aureus, Streptococcus spp. Prevotella (except Prevotella Bivia).

    Amoxicillin and clavulanic acid are completely dissociated in water solution in physiological pH. Both ingredients are well absorbed and quickly after drinking. The absorption of amoxicillin/ clavulanic acid is improved when taken at the beginning of the meal. Oral bioavailability of amoxicillin and clavulanic acid is about 70%. The characteristics of two plasma components are the same and the time to reach the peak concentration (TMAX) of each component is about 1 hour.

    The following pharmacokinetic parameters are recorded when using amoxicillin/clavulanic acid is 45 mg/3.2 mg/kg every 12 hours for children.

    content cmax (µg/ml) max (hour)

    auc (0-t)

    (µg. t1/2 (hours)

    Amoxicilin

    15,7

    ± 7.7

    2.0

    (1,0 - 4.0)

    59,8

    ± 20.0

    1.4

    ± 0.35

    Clavulanic

    1.7

    ± 0.9

    1.1

    (1,0 - 4.0)

    4.0

    ± 1.9

    1.1

    ± 0.29

    * Middle (interval)

    distribution

    About 25% of total clavulanic acid in plasma and 18% of total amoxicillin in plasma is linked to protein. Expression distribution volume is about 0.3 to 0.4 l/kg for amoxicillin and about 0.2 l/kg for clavulanic acid.

    After intravenous injection, both amoxicillin and clavulanic acid have been found in gallbladder, abdominal tissue, skin, fat, muscle tissue, fluid and abdominal fluid, bile and pus of the wound. Amoxicillin is not much distributed in cerebrospinal fluid.

    Animal studies show that there is no storage of drug metabolites in the body. Like other antibiotics penicillin, amoxicillin can be distributed into breast milk. A very small amount of Clavulanic acid has also been discovered in breast milk.

    both amoxicillin and clavulanic acid have passed the placenta fence.

    transformation

    about 10 - 25% amoxicillin in the starting dose is excreted in urine in the form of peniciloic acid that does not work. Clavulanic acid metabolizes a lot in the human body, excreted into urine, feces and in the form of carbon dioxid in exhaled gas.

    Elimination

    Amoxicillin is excreted mainly through the kidneys, while clavulanic acid is eliminated by the mechanism through both the kidneys and external kidneys.

    Combining amoxicillin/ clavulanic acid has an average selling time for about 1 hour and total clearance of about 25 l/ hour in healthy people. Nearly 60 - 70% amoxicillin and 40 - 65% of Clavulanic acid are eliminated in urine in the form of unchanged in the first 6 hours after taking a single tablet with amoxicillin/ clavulanic acid with a content of 250 mg/ 125 mg or 500 mg/ 125 mg. Different studies show that about 50 - 85% amoxicillin and 27 - 60% of Clavulanic acid are eliminated through urine after 24 hours. Clavulanic acid is most eliminated in the first 2 hours after taking the drug.

    Concentrated with probenecid may slow down amoxicillin, but does not affect the elimination of clavulanic acid through the kidney.

    Age

    Amoxicillin's sale time in children from 3 months to 2 years old is equivalent to older children and adults. In newborns (including premature babies), in the first week after birth, do not use more than 2 times/day because the emissions through the kidneys have not been fully developed. Because the elderly people have a higher impairment of renal function, it is necessary to be cautious when choosing the dose and monitoring the kidney function throughout the treatment process.

    Sex

    After drinking amoxicilin/ clavulanic acid in healthy women and men shows that gender does not significantly affect the pharmacokinetics of both amoxicillin and clavulanic acid.

    kidney failure

    The total serum clearance coefficient of amoxicillin/ clavulanic acid decreases corresponding to the impaired renal function. The decrease in amoxicillin clearance is more pronounced than clavulanic acid, as the ratio of amoxicillin eliminates through the kidneys is higher. Therefore, the dose for patients with renal impairment must prevent excessive accumulation of amoxicillin while maintaining the appropriate clavulanic acid level.

    liver failure

    Patients with liver failure should be carefully indicated and monitored liver function periodically.

  • Before taking Niflad ES 600mg/42.9mg Imexpharm Treatment of skin infections, chronic purulent dermatitis (4 blisters x 7 tablets)

    How to use

    Niflad ES dispersed tablets are used by oral: mixing pills in a little water, stirring and drinking immediately. You can put the pill in the mouth to disintegrate, then swallow and drink immediately with plenty of water.

    Should take medicine before meals to minimize the possibility of intolerance in the gastrointestinal tract.

    Instructions on how to open the packaging:

    Use your hands or sharp tools to open in the border on the blister to get the tablet.

    Do not press, press to remove the pill from the blister to avoid the broken or break. If the pills are not intact, still make the drug into the water and use it according to the instructions.

    Use the tablet immediately after removing the blister.

    Dosage

    Take the drug as directed by the doctor and the right dose in the prescription.

    recommended dose 90 mg amoxicillin/6.4 mg Clavulanic acid/kg/day, divided into 2 times/day.

    For children weighing

    Weight

    Dosage for reference is calculated in the form of preparation

    11 kg to under 16 kg 1 tablet/time, 2 times/day

    16 kg to less than 30 kg 1 - 2 capsules/time, 2 times/day 31 kg to under 40 kg 2 - 2 - 2 -tablets 2 times/day

    Patients with kidney failure, liver failure: Caution when using (see warning and caution when taking the drug).

    What to do when overdose?

    overdose:

    Symptoms on the gastrointestinal tract and water balance disorders, electrolytes may be an expression of overdose. Observed the urinary amoxicillin crystal, in some cases, the kidney failure (see the warning and caution when taking the drug).

    Seism can occur in patients with renal failure or high doses.

    How to handle:

    Stop using drugs, treat symptoms on the gastrointestinal tract and monitor water and electrolyte balance.

    It is possible to remove amoxicillin/ acid clavulanic from circulation by hemolysis method.

    What to do when you forget 1 dose? Use the next dose after at least 4 hours. Do not use double dose to compensate for the forgotten dose.

    Side Effects

    The unwanted effects of the drug (ADRS) is the most common ADRS) is diarrhea, nausea and vomiting.

    The frequency is determined as follows: Very common (ADR ≥ 1/10), common (1/100 ≤ ADR

    Agency system

    Frequency

    Unwanted effects

    infections and parasites common Candida fungal infection on the skin mucosa. Blood rare leukemia has recovered (including neutropen leukopenia), platelet reduction. Knowing Neurological angioema, anaphylaxis, serum -like syndrome, hypersensitivity vascular disease. Gastrointestinal disorder

    is common

    diarrhea, nausea, vomiting. Mat less common Increase AST and/or Alt. Meet diverse Hong Ban. Urine

    If allergic reactions occur such as erythema, quincke edema, anaphylactic shock, Stevens-Johnson syndrome, stop the drug, immediately treat emergency treatment with Adrenalin, oxygen breathing, intravenous corticosteroids and ventilation, including endotracheal placement and never treated with drugs containing antibiotic components of penicilin or cephalosporin.

    Management when fake colitis:

  • Mild: Stop drugs.
  • Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Niflad ES 600mg/42.9mg contraindications in the following cases:

  • Patients with amoxicillin, clavulanic acid, other antibiotics belong to the penicillin group or any component of the drug (see the ingredient section of the formula).

    Be cautious when using

    Precautions when using amoxicillin/clavulanic acid for the following objects:

    Patients with a history of allergies to cephem antibiotics.

    Patients with family history are susceptible to allergy symptoms such as bronchial asthma, rash, urticaria ...

    Patients with poor absorption, nutrition on the gastrointestinal tract and poorly.

    Before starting treatment with amoxicillin/ clavulanic acid, the patient's allergic history must be carefully investigated with penicillin, cephalosporin or other beta-lactam drugs.

    Severe hypersensitivity reactions and sometimes fatal (such as anaphylaxis) have been recorded in patients treated with penicillin groups. These reactions often occur in patients with a history of allergies to penicillin and other allergens. If the allergic reaction occurs, it is necessary to stop using amoxicillin/ clavulanic acid and other treatments for other appropriate treatment.

    Convulsions can occur in patients with impaired renal function or high doses of drugs. Therefore, caution when taking medication for patients with renal impairment and adjusting the dose according to creatinine clearance.

    Using allopurinol while being treated with amoxicillin may increase the risk of skin allergies.

    Take the drug that lasts sometimes causes excessive growth of non -sensitive bacteria.

    The appearance of the whole body erythema with pustules at the beginning of the treatment may be a manifestation of acute generalized exanthematous pustulosis (AGEP). If these manifestations appear, the patient should stop the drug and contraindes to any drug containing amoxicillin.

    Be cautious when used in combination with amoxicillin/ clavulanic acid for patients with impaired liver function.

    The side effects of the drug in the liver mainly occur in male patients, the elderly and the patient must be treated for a long time, rarely occurs in children. Typically, signs and symptoms usually occur during the process or after a short time of treatment, but in some cases, it may not be clear until several weeks after stopping treatment. These symptoms can often recover on their own. However, there are still cases of serious, even death, but very rare, mainly in patients with serious illness or use in combination with drugs that are at risk of affecting the liver.

    Colitis associated with antibiotics has been reported with almost all antibacterial agents including amoxicillin and can fluctuate in a level from mild to life -threatening. Therefore, it is necessary to diagnose this disease in patients with diarrhea during or after medication. If colitis is related to antibiotics, it is necessary to stop using amoxicillin/ clavulanic acid immediately and conduct appropriate treatments. Contraindicated to use intestinal iron inhibitors in these cases.

    Periodically check the functions of organs such as kidney and liver function, hematological index during long -term treatment.

    Prothrombin time has been reported in patients treated with amoxicillin/ clavulanic acid, but it rarely occurs. The patient's condition should be monitored when used simultaneously with anticoagulants. It is possible to adjust the oral anticoagulant dose if necessary to maintain the concentration of anticoagulants as desired.

    Very rare cases of urinary crystal phenomenon in patients who reduce urine excretion, mainly in patients taking drugs in the form of injection. Patients should maintain enough oral fluid and the amount of urine output to reduce the ability to cause urinary amoxicillin crystals, especially when taking the drug in high doses. In patients with urinary tract placement, regular checkpoints need catheter.

    During the treatment of amoxicillin, the glucose oxidase enzyme should be used when the glucose test is needed in the urine because of the non -enzyme methods that can give false positive results.

    Clavulanic acid in the drug can cause nonsense cohesion of IgG and albumin on the membrane of red blood cells, resulting in a false positive result of the Coombs solution.

    The drug can cause false positive testing Bio-Rad Laboratories Platelia Aspergillus EIA due to cross-reactions with polysaccharids and polyfuranose are not Aspergillus. Therefore, for patients who are taking amoxicilin and clavulanic acid, cautious if there is a positive result when testing by this method and should be further determined by other diagnostic methods.

    Information related to the excipients of the drug:

    The drug contains fd & c yellow 6 alum lake color excipients so it is necessary to be cautious when taking the drug for patients with atopic allergies.

    The effect of drugs on driving and operating machinery

    There are no studies on the effects of the drug on the ability to drive and operate machinery. However, because the drug can cause some unwanted effects such as allergic reactions, dizziness, convulsions ... Therefore, patients should not drive or operate machinery while taking the drug.

    Use drugs for women during pregnancy and lactation

    Due to the safety of treatment with amoxicillin/ acid Clavulanic acid for pregnant women and breastfeeding has not been studied, so only use drugs for these subjects when it is really necessary and after assessing the benefits for mothers surpass the risk of breastfed babies/ breastfeeding.

    Drug interaction

    Interaction of drugs:

    Probenecid:

    Avoid simultaneously with Probenecid. Probenecid reduces amoxicillin secretion in the renal tubules, thus increasing and prolonging the concentration of amoxicillin in the blood but does not affect clavulanic acid.

    Oral anticoagulant drugs:

    Oral anticoagulants and penicillin antibiotics have been widely used in reality without noting any interactions. However, in the literature, it refers to the extension of prothrombin time, increasing the international normalization index (INR) in patients using acenocoumarol or warfarin simultaneously with amoxicillin. If it is necessary to use simultaneously, should carefully monitor Prothrombin or INR time when starting or stopping Niflad ES. Can adjust anticoagulant dose if needed.

    Oral contraceptive pills:

    The drug can reduce the effectiveness of oral contraceptives due to drugs that change the intestinal bacteria and inhibit the intestinal reabsorption of oral contraceptive pills.

    mycophenolat mofetil:

    In patients who are taking Mycophenolat Mofetil, there has been a report on the 50% reduction of concentration before the dose of metabolites with mycophenolic acid activity (MPA) after treatment with amoxicilin/ clavulanic acid. The change of concentration before this dose may not exactly show changes in the overall MPa exposure level. Therefore, it is not necessary to adjust the dose of mycophenolat mofetil without clinical evidence of grafted complications. However, clinical monitoring should be closely monitored during the use of the drug and a short time after stopping treatment with antibiotics.

    Diagnostic tests:

    Glucose test in urine: During the treatment with amoxicillin, the glucose glucose enzyme should be used when the glucose test is needed in the urine because of the non -enzyme method that can give false positive results.

    Coombs: Clavulanic acid causes narrative cohesion of IgG and albumin on the membrane of red blood cells, resulting in a false positive result of the Coombs solution.

    Bio-Rad Laboratories Platelia Aspergillus Eia: The drug can cause fake positive testing Bio-Rad Laboratories Platelia Aspergillus EIA due to cross-reactions with polysaccharides and polyfuranose are not Aspergillus. Therefore, for patients who are taking amoxicilin and clavulanic acid, cautious if there is a positive result when testing by this method and should be further determined by other diagnostic methods.

    The cavalry of the drug:

    Due to the lack of studies on the correspondence of the drug, not mixing this drug with other drugs.

  • Storage

    not more than 30 degrees C, avoid moisture and avoid light.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords